S&P 500
(0.05%) 5 064.28 points
Dow Jones
(0.45%) 37 907 points
Nasdaq
(0.09%) 15 899 points
Oil
(0.29%) $85.66
Gas
(-0.35%) $1.685
Gold
(0.81%) $2 402.20
Silver
(-1.12%) $28.40
Platinum
(-0.08%) $980.20
USD/EUR
(-0.03%) $0.941
USD/NOK
(0.36%) $10.98
USD/GBP
(0.07%) $0.804
USD/RUB
(-0.38%) $93.15

Realtime updates for Sihuan Pharmaceutical [0460.HK]

Exchange: HKSE Industry: Drug Manufacturers
Last Updated16 Apr 2024 @ 04:08

-3.85% HKD 0.500

Live Chart Being Loaded With Signals

Commentary (16 Apr 2024 @ 04:08):

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China...

Stats
Today's Volume 8.39M
Average Volume 8.01M
Market Cap 4.64B
EPS HKD0 ( 2024-03-27 )
Last Dividend HKD0.0370 ( 2023-06-06 )
Next Dividend HKD0 ( N/A )
P/E -50.00
ATR14 HKD0.00300 (0.60%)

Volume Correlation

Long: -0.12 (neutral)
Short: 0.00 (neutral)
Signal:(36.79) Neutral

Sihuan Pharmaceutical Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sihuan Pharmaceutical Correlation - Currency/Commodity

The country flag 0.47
( neutral )
The country flag 0.48
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.11
( neutral )

Sihuan Pharmaceutical Financials

Annual 2022
Revenue: HKD2.18B
Gross Profit: HKD1.49B (68.20 %)
EPS: HKD-0.210
Q2 2023
Revenue: HKD1.06B
Gross Profit: HKD747.73M (70.83 %)
EPS: HKD-0.00530
Q2 2022
Revenue: HKD1.46B
Gross Profit: HKD1.00B (68.55 %)
EPS: HKD0.00430
Q3 2019
Revenue: HKD721.74M
Gross Profit: HKD573.73M (79.49 %)
EPS: HKD-0.0728

Financial Reports:

No articles found.

Sihuan Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0.0360
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.0370
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Sihuan Pharmaceutical Dividend Information - No Dividend Player

Dividend Sustainability Score: 1.766 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.0390 2011-09-21
Last Dividend HKD0.0370 2023-06-06
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 23 --
Total Paid Out HKD0.764 --
Avg. Dividend % Per Year 0.00% --
Score 0.8 --
Div. Sustainability Score 1.766
Div.Growth Potential Score 0
Div. Directional Score 0.224 --
Next Divdend (Est)
(2024-04-17)
HKD0.0364 Estimate 3.62 %
Dividend Stability
0.29 Very Poor
Dividend Score
0.80
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
3908.HK Ex Dividend Junior 2023-07-04 Sporadic 0 0.00%
1776.HK Ex Dividend Junior 2023-07-11 Annually 0 0.00%
0819.HK Ex Dividend Junior 2023-06-13 Annually 0 0.00%
2357.HK Ex Dividend Junior 2023-05-24 Annually 0 0.00%
1346.HK Ex Dividend Knight 2023-09-12 Annually 0 0.00%
0392.HK Ex Dividend Junior 2023-09-22 Semi-Annually 0 0.00%
6198.HK Ex Dividend Knight 2023-06-08 Annually 0 0.00%
1897.HK Ex Dividend Knight 2023-07-05 Semi-Annually 0 0.00%
0922.HK Ex Dividend Junior 2023-09-13 Sporadic 0 0.00%
0057.HK Ex Dividend Knight 2023-09-01 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.04701.500-0.940-1.411[0 - 0.5]
returnOnAssetsTTM-0.004221.200-0.141-0.169[0 - 0.3]
returnOnEquityTTM-0.01091.500-1.232-1.848[0.1 - 1]
payoutRatioTTM-6.01-1.000-10.0010.00[0 - 1]
currentRatioTTM2.840.8000.7800.624[1 - 3]
quickRatioTTM2.230.8001.6141.291[0.8 - 2.5]
cashRatioTTM1.6651.5001.8622.79[0.2 - 2]
debtRatioTTM0.110-1.5008.16-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.003042.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM-0.004882.00-0.00244-0.00488[0 - 20]
debtEquityRatioTTM0.294-1.5008.82-10.00[0 - 2.5]
grossProfitMarginTTM0.7081.0001.5291.529[0.2 - 0.8]
operatingProfitMarginTTM0.05731.000-0.854-0.854[0.1 - 0.6]
cashFlowToDebtRatioTTM0.02181.000-0.990-0.990[0.2 - 2]
assetTurnoverTTM0.08970.800-2.74-2.19[0.5 - 2]
Total Score1.766

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-91.771.000-9.370[1 - 100]
returnOnEquityTTM-0.01092.50-0.792-1.848[0.1 - 1.5]
freeCashFlowPerShareTTM-0.004882.00-0.00163-0.00488[0 - 30]
dividendYielPercentageTTM7.561.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.003042.0010.0010.00[0 - 30]
payoutRatioTTM-6.011.500-10.0010.00[0 - 1]
pegRatioTTM-1.0251.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.02681.000-1.8290[0.1 - 0.5]
Total Score-1.318

Sihuan Pharmaceutical

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators